Nuveen’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-400,154
| Closed | -$5.88M | – | 3261 |
|
|
2025
Q3 | $5.88M | Sell |
400,154
-238,673
| -37% | -$2.43M | ﹤0.01% | 1830 |
|
|
2025
Q2 | $6.27M | Sell |
638,827
-397,130
| -38% | -$3.29M | ﹤0.01% | 1768 |
|
|
2025
Q1 | $7.53M | Buy |
1,035,957
+749,465
| +262% | +$6.55M | ﹤0.01% | 1712 |
|
|
2024
Q4 | $2.24M | Sell |
286,492
-3,420
| -1% | -$28.2K | ﹤0.01% | 2341 |
|
|
2024
Q3 | $2.15M | Buy |
289,912
+6,811
| +2% | +$57.3K | ﹤0.01% | 2381 |
|
|
2024
Q2 | $2.27M | Sell |
283,101
-267,493
| -49% | -$2.39M | ﹤0.01% | 2323 |
|
|
2024
Q1 | $6.41M | Buy |
550,594
+308,205
| +127% | +$3.41M | ﹤0.01% | 1849 |
|
|
2023
Q4 | $2.71M | Sell |
242,389
-155,413
| -39% | -$1.43M | ﹤0.01% | 2276 |
|
|
2023
Q3 | $6.14M | Buy |
397,802
+21,795
| +6% | +$366K | ﹤0.01% | 1760 |
|
|
2023
Q2 | $7.13M | Buy |
+376,007
| New | +$6.6M | ﹤0.01% | 1715 |
|
|
2022
Q2 | – | Sell |
-38,906
| Closed | -$149K | – | 3326 |
|
|
2022
Q1 | $149K | Sell |
38,906
-17,234
| -31% | -$111K | ﹤0.01% | 3223 |
|
|
2021
Q4 | $664K | Sell |
56,140
-4,152
| -7% | -$65.6K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $1.28M | Buy |
60,292
+5,678
| +10% | +$104K | ﹤0.01% | 2884 |
|
|
2021
Q2 | $1.02M | Sell |
54,614
-10,298
| -16% | -$230K | ﹤0.01% | 2996 |
|
|
2021
Q1 | $1.54M | Sell |
64,912
-7,476
| -10% | -$173K | ﹤0.01% | 2729 |
|
|
2020
Q4 | $1.76M | Buy |
72,388
+5,712
| +9% | +$146K | ﹤0.01% | 2570 |
|
|
2020
Q3 | $1.71M | Buy |
+66,676
| New | +$2.11M | ﹤0.01% | 2458 |
|
|
2020
Q2 | – | Sell |
-43,630
| Closed | -$1.1M | – | 3301 |
|
|
2020
Q1 | $1.1M | Buy |
+43,630
| New | +$1.28M | ﹤0.01% | 2480 |
|
Other funds holding ETNB
Nuveen's ETNB Position: Q4 2025 in Review
Nuveen sold out of 89bio (ETNB) in Q4 2025, closing a stake of 400,154 shares — an estimated $5.88M sold.
Nuveen first reported a position in ETNB in Q1 2020 and held it in 18 quarters. The position peaked at $7.53M in Q1 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Nuveen reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Nuveen sold 400,154 89bio shares in Q4 2025, an estimated $5.88M.
- Nuveen first reported a position in 89bio in Q1 2020 and held it in 18 quarters.
- Nuveen's 89bio position peaked at $7.53M in Q1 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.